Dissemination of the Acinetobacter baumannii isolates belonging to global clone 2 containing AbGRI resistance islands in a referral hospital

ABSTRACT Acinetobacter baumannii strains belonging to global clone 2 (GC2) contain resistance islands (AbGRIs), which are composed of genes conferring resistance to older and newer antibiotics. Here, to locate these genes in AbGRIs, the GC2 strains from Tehran, Iran were examined. Among the 170 A. baumannii, 90 isolates were identified as GC2. Of the genes that confer resistance to older antibiotics, tetA(B), tetR(B) (tetracyclines), strA, and strB (aminoglycosides) were located in AbGRI1 of 65 GC2 isolates (72.2%). Of the other aminoglycosides, the aphA1b was located in AbGRI2-12b (63.6%), AbGRI2-12a (21.2%), or AbGRI2-1 (15.1%). The aacC1 and aadA1 genes were co-located within AbGRI2-1 (5.5%). The armA was located in AbGRI3-4 (77.7%) and AbGRI3ABI221 (22.2%). Of sulfonamides, the sul1 was located within AbGRI2-1 (5.5%). Of beta-lactams, the blaTEM was located in AbGRI2-12b (42%), AbGRI2-12a (14%), AbGRI2-1 (10%), or AbGRI2ABI257 (34%). The oxa23 gene conferring resistance to newer antibiotics (carbapenems) was located in AbaR4 (81.1%); of them, the AbaR4 was located within AbGRI1 in 45.2% of the isolates. This study showed that the GC2 isolates, which contained at least one AbGRI, disseminate in the hospital. Hence, it is likely that the AbGRIs play a significant role in conferring resistance to older and newer antibiotics in GC2 isolates from Iran. IMPORTANCE The majority of Acinetobacter baumannii isolates that are resistant to multiple antibiotics belong to one of the two major global clones, namely global clone 1 (GC1) and global clone 2 (GC2). The resistance islands, which contain variable assortments of transposons, integrons, and specific resistance genes, have been characterized in the genome of these GCs. In GC2 A. baumannii, the chromosomally located A. baumannii genomic resistance islands (AbGRIs) carry the genes conferring resistance to older and newer antibiotics. In this context, we tested whether GC2 isolates collected from a referral hospital carry the AbGRIs containing these genes. This study provided evidence for the circulation of the GC2 A. baumannii strains harboring AbGRI resistance islands between different wards of a referral hospital. The majority of Acinetobacter baumannii isolates that are resistant to multiple antibiotics belong to one of the two major global clones, namely global clone 1 (GC1) and global clone 2 (GC2). The resistance islands, which contain variable assortments of transposons, integrons, and specific resistance genes, have been characterized in the genome of these GCs. In GC2 A. baumannii, the chromosomally located A. baumannii genomic resistance islands (AbGRIs) carry the genes conferring resistance to older and newer antibiotics. In this context, we tested whether GC2 isolates collected from a referral hospital carry the AbGRIs containing these genes. This study provided evidence for the circulation of the GC2 A. baumannii strains harboring AbGRI resistance islands between different wards of a referral hospital.

[1]  A. Abdollahi,et al.  Mobile genetic elements carrying aminoglycoside resistance genes in Acinetobacter baumannii isolates belonging to global clone 2 , 2023, Frontiers in Microbiology.

[2]  M. Hamidian,et al.  Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain , 2021, The Journal of antimicrobial chemotherapy.

[3]  K. Jolley,et al.  Comparative Analysis of the Two Acinetobacter baumannii Multilocus Sequence Typing (MLST) Schemes , 2019, Front. Microbiol..

[4]  M. Hamidian,et al.  The AbaR antibiotic resistance islands found in Acinetobacter baumannii global clone 1 - Structure, origin and evolution. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[5]  Grace A. Blackwell Antibiotic resistance in global clone 2 Acinetobacter baumannii from Singapore , 2017 .

[6]  M. Hamidian,et al.  Origin of the AbGRI1 antibiotic resistance island found in the comM gene of Acinetobacter baumannii GC2 isolates , 2017, The Journal of antimicrobial chemotherapy.

[7]  K. Holt,et al.  Variants of AbGRI3 carrying the armA gene in extensively antibiotic-resistant Acinetobacter baumannii from Singapore , 2017, The Journal of antimicrobial chemotherapy.

[8]  H. Zeraati,et al.  Trend of extensively drug‐resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3‐year period , 2016, Letters in applied microbiology.

[9]  K. Ko,et al.  Occurrence of Diverse AbGRI1-Type Genomic Islands in Acinetobacter baumannii Global Clone 2 Isolates from South Korea , 2016, Antimicrobial Agents and Chemotherapy.

[10]  R. Hall,et al.  Loss and gain of aminoglycoside resistance in global clone 2 Acinetobacter baumannii in Australia via modification of genomic resistance islands and acquisition of plasmids. , 2016, The Journal of antimicrobial chemotherapy.

[11]  Mark B. Schultz,et al.  Five decades of genome evolution in the globally distributed, extensively antibiotic-resistant Acinetobacter baumannii global clone 1 , 2016, Microbial genomics.

[12]  R. Hall,et al.  Evolution of AbGRI2-0, the Progenitor of the AbGRI2 Resistance Island in Global Clone 2 of Acinetobacter baumannii , 2015, Antimicrobial Agents and Chemotherapy.

[13]  Steven J. Nigro Analysis of Australian multiply-antibiotic resistant Acinetobacter baumannii belonging to global clone 2 , 2014 .

[14]  S. Koo,et al.  Dissemination of an AbaR-type Resistance Island in Multidrug-resistant Acinetobacter baumannii Global Clone 2 in Daejeon of Korea , 2013 .

[15]  R. Hall,et al.  Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes , 2013, PloS one.

[16]  I. Paulsen,et al.  A novel family of genomic resistance islands, AbGRI2, contributing to aminoglycoside resistance in Acinetobacter baumannii isolates belonging to global clone 2. , 2013, The Journal of antimicrobial chemotherapy.

[17]  A. Sundsfjord,et al.  Dissemination of a Carbapenem-Resistant Acinetobacter baumannii Strain Belonging to International Clone II/Sequence Type 2 and Harboring a Novel AbaR4-Like Resistance Island in Latvia , 2012, Antimicrobial Agents and Chemotherapy.

[18]  K. Ko,et al.  Variations of AbaR4-Type Resistance Islands in Acinetobacter baumannii Isolates from South Korea , 2012, Antimicrobial Agents and Chemotherapy.

[19]  R. Hall,et al.  Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate. , 2012, The Journal of antimicrobial chemotherapy.

[20]  E. Sužiedėlienė,et al.  Novel Variants of AbaR Resistance Islands with a Common Backbone in Acinetobacter baumannii Isolates of European Clone II , 2012, Antimicrobial Agents and Chemotherapy.

[21]  S. Brisse,et al.  Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  L. Dijkshoorn,et al.  The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool , 2010, PloS one.

[23]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[24]  M. Kaufmann,et al.  Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  F. Rodríguez-Valera,et al.  Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii , 2007, Journal of Clinical Microbiology.

[26]  M. Kaufmann,et al.  Identification of Acinetobacter baumannii by Detection of the blaOXA-51-like Carbapenemase Gene Intrinsic to This Species , 2006, Journal of Clinical Microbiology.

[27]  E Bergogne-Bérézin,et al.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features , 1996, Clinical microbiology reviews.

[28]  S. Amyes,et al.  ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii , 1993 .

[29]  J. A. Morello Bailey and Scott's Diagnostic Microbiology , 1982 .

[30]  OUP accepted manuscript , 2021, Journal of Antimicrobial Chemotherapy.

[31]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[32]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .